Ampd3-flox Mouse
一般名
Ampd3-flox
製品ID
S-CKO-01191
背景情報
C57BL/6JCya
系統ID
CKOCMP-11717-Ampd3-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Ampd3-flox Mouse(カタログ番号S-CKO-01191)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Ampd3-flox
系統ID
CKOCMP-11717-Ampd3-B6J-VA
遺伝子名
製品ID
S-CKO-01191
遺伝子別名
--
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 7
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000005829
NCBIトランスクリプトID
NM_009667
ターゲット領域
Exon 3
有効領域の大きさ
~1.1 kb
遺伝子研究の概要
Ampd3, also known as adenosine monophosphate deaminase 3, is an isoenzyme involved in the regulation of the energetic metabolism of mammalian cells, catalyzing the conversion of AMP to IMP [3,5]. It plays a crucial role in nucleotide metabolism and energy charge, and is especially important in erythrocytes where it is the key catabolic enzyme for 5'-AMP [7]. Genetic models, such as gene knockout (KO) mice, have been instrumental in studying its functions.
In a mouse model of chronic kidney disease (CKD), genetic ablation of Ampd3 in erythrocytes preserves the adenine nucleotide pool, activates the AMPK-BPGM axis, enhances O₂ delivery and antioxidative stress capacity, protecting against renal hypoxia, damage, and CKD progression. This shows that Ampd3 is part of an erythrocyte purinergic hypoxia-sensing and energy-regulating axis [1]. In DOX-induced cardiotoxicity, Ampd3 knockout mice have improved ejection fractions and reduced myocardial injury. Transcriptome sequencing reveals reduced levels of related proteins, and it is shown that Ampd3 interacts with HSP90α, activating DRP1 and leading to mitochondrial fission, ROS release, and ferroptosis [2]. In gastrointestinal stromal tumors (GISTs), depletion of Ampd3 in GIST-T1 cells using siRNA suppresses cell migration and invasion, and sensitizes cells to the tyrosine kinase inhibitor imatinib, indicating its association with the malignant characteristics of GISTs [4]. In anthrax LeTx-induced macrophage cell death, Ampd3 deficiency impairs an unknown downstream event linked to cell death, despite not affecting LeTx entry or MKK cleavage [5]. In autosomal dominant polycystic kidney disease (ADPKD) mouse models, inhibition of Ampd3, a SE-driven and CDK7-controlled metabolic target gene, delays cyst growth [6].
In conclusion, Ampd3 plays diverse and essential roles in various biological processes and disease conditions. KO mouse models have been vital in revealing its role in CKD, cardiomyopathy, GISTs, macrophage cell death, and ADPKD. These studies provide insights into the underlying mechanisms and potential therapeutic targets for these diseases.
References:
1. Chen, Changhan, Xie, TingTing, Zhang, Yujin, D'Alessandro, Angelo, Xia, Yang. 2023. Erythrocyte ENT1-AMPD3 Axis is an Essential Purinergic Hypoxia Sensor and Energy Regulator Combating CKD in a Mouse Model. In Journal of the American Society of Nephrology : JASN, 34, 1647-1671. doi:10.1681/ASN.0000000000000195. https://pubmed.ncbi.nlm.nih.gov/37725437/
2. Cheng, Liting, Zhu, Mingxiang, Xu, Xiang, Liu, Chunlei, He, Kunlun. 2024. AMPD3 promotes doxorubicin-induced cardiomyopathy through HSP90α-mediated ferroptosis. In iScience, 27, 111005. doi:10.1016/j.isci.2024.111005. https://pubmed.ncbi.nlm.nih.gov/39474068/
3. Hsu, Cheng-Ming, Chang, Shun-Fu, Tsai, Yao-Te, Lin, Sheng-Fung, Yang, Ming-Yu. . Down-regulation of AMPD3 Is Associated With Poor Survival in Head and Neck Squamous Cell Carcinoma. In In vivo (Athens, Greece), 36, 704-712. doi:10.21873/invivo.12756. https://pubmed.ncbi.nlm.nih.gov/35241525/
4. Wong, Meihong, Funasaka, Kohei, Obayashi, Tomohiko, Goto, Hidemi, Senga, Takeshi. 2016. AMPD3 is associated with the malignant characteristics of gastrointestinal stromal tumors. In Oncology letters, 13, 1281-1287. doi:10.3892/ol.2016.5532. https://pubmed.ncbi.nlm.nih.gov/28454247/
5. Lee, Sangun, Wang, Yanhai, Kim, Sung Ouk, Han, Jiahuai. 2011. AMPD3 is involved in anthrax LeTx-induced macrophage cell death. In Protein & cell, 2, 564-72. doi:10.1007/s13238-011-1078-2. https://pubmed.ncbi.nlm.nih.gov/21822801/
6. Mi, Zeyun, Song, Yandong, Cao, Xinyi, Zhang, Lirong, Chen, Yupeng. 2020. Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease. In Nature metabolism, 2, 717-731. doi:10.1038/s42255-020-0227-4. https://pubmed.ncbi.nlm.nih.gov/32694829/
7. Daniels, Isadora Susan, O Brien, William G, Nath, Vinay, Zhao, Zhaoyang, Lee, Cheng Chi. 2013. AMP deaminase 3 deficiency enhanced 5'-AMP induction of hypometabolism. In PloS one, 8, e75418. doi:10.1371/journal.pone.0075418. https://pubmed.ncbi.nlm.nih.gov/24066180/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
